Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Baclofen Distribution Pilot
NCT02903823Phase 4Completed
- Sponsor
- Vanderbilt University
- Start
- Apr 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of baclofen in Spasticity, sponsored by Vanderbilt University. Primary endpoints: Subjects Experiencing Maximal Modified Ashworth Score Change From Baseline - Spasticity of Cerebral Origin and Subjects Experiencing Maximal Modified Ashworth Score Change From Baseline - Spasticity of Spinal Origin. Started Apr 2016; status: completed.
02
Drugs
baclofen
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT02903823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02903823.